RiskReversal Pod cover image

Okay, Computer: Ro CEO Zach Reitano on Weight Loss Drugs

RiskReversal Pod

00:00

Novo Nordisk's Row Body Program Is in Short Supply

Wigovie, Ozempic and Sixenda are all in short supply. Wigovie is a daily injection where patients see about 9% weight loss over the course of a year. We've proactively messaged patients both before on our landing page as well as right after they sign up. And we're doing whatever we can to add more drugs to the formulary by crediting patients,. But this is going to be a challenging moment for us.

Play episode from 14:23
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app